These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39067959)

  • 1. Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients - A study from South Delhi, New Delhi, India.
    Kumar L; Kumar S; Vohra V; Mohan K; Khayyam KU
    Indian J Tuberc; 2024; 71 Suppl 1():S72-S76. PubMed ID: 39067959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.
    Vashakidze S; Gogishvili S; Nikolaishvili K; Dzidzikashvili N; Tukvadze N; Blumberg HM; Kempker RR
    Ann Thorac Surg; 2013 Jun; 95(6):1892-8. PubMed ID: 23642435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
    Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS
    Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
    Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
    PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes.
    Podewils LJ; Gler MT; Quelapio MI; Chen MP
    PLoS One; 2013; 8(7):e70064. PubMed ID: 23922904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India.
    Datta BS; Hassan G; Kadri SM; Qureshi W; Kamili MA; Singh H; Manzoor A; Wani MA; Shamas-u-Din ; Thakur N
    J Infect Dev Ctries; 2009 Nov; 4(1):19-23. PubMed ID: 20130374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.
    Cavanaugh JS; Kazennyy BY; Nguyen ML; Kiryanova EV; Vitek E; Khorosheva TM; Nemtsova E; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1069-74. PubMed ID: 22691694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for interruption of anti-tubercular treatment among the retreatment patients in category II of RNTCP in Chandigarh, north India.
    Sarpal SS; Goel NK; Kumar D; Janmeja AK
    Indian J Tuberc; 2014 Apr; 61(2):121-8. PubMed ID: 25509934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Affecting Treatment Compliance among Tuberculosis Patients at Dots Centre after Introduction of Daily Regimen and Fixed Dose Combination.
    C H; Mc R; Jamal S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
    Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
    Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia.
    Bastard M; Sanchez-Padilla E; Hewison C; Hayrapetyan A; Khurkhumal S; Varaine F; Bonnet M
    J Infect Dis; 2015 May; 211(10):1607-15. PubMed ID: 25312040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?
    Balabanova Y; Ignatyeva O; Fiebig L; Riekstina V; Danilovits M; Jaama K; Davidaviciene E; Radiulyte B; Popa CM; Nikolayevskyy V; Drobniewski F
    Thorax; 2016 Sep; 71(9):854-61. PubMed ID: 27012887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.
    Myneedu VP; Singhal R; Khayyam KU; Sharma PP; Bhalla M; Behera D; Sarin R
    J Epidemiol Glob Health; 2015 Dec; 5(4):365-73. PubMed ID: 25944154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home based care to multi-drug resistant tuberculosis patients: A pilot study.
    Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK
    Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.
    OʼDonnell MR; Wolf A; Werner L; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):22-9. PubMed ID: 24872138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia.
    Jakubowiak W; Bogorodskaya E; Borisov S; Danilova I; Kourbatova E
    Int J Infect Dis; 2009 May; 13(3):362-8. PubMed ID: 19008141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.